Skip to content

Independent register of U.S. FDA drug recalls · updated Oct 10, 2026

FDA Drug Recalls

1,018 recalls, newest first

Apr 14, 2022 Class III · Low risk

Phenobarbital Elixir

Does Not Meet USP or OTC Monograph: Product exceeds USP specification for alcohol content

Terminated Unapproved drug Monarch PCM, LLC NDC 69367-172-16 D-0878-2022

Apr 13, 2022 Class II · Moderate risk

Paracentesis/Thoracentises Tray

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office D-1122-2022

Apr 13, 2022 Class II · Moderate risk

Biopsy and Aspiration Tray Bone Marrow Illinois 11GX4

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office D-1121-2022

Apr 13, 2022 Class II · Moderate risk

Intralipid

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0338-0519-58 D-1120-2022

Apr 13, 2022 Class II · Moderate risk

Intralipid

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0338-0519-09 D-1119-2022

Apr 13, 2022 Class II · Moderate risk

Cefazolin for injection USP

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0264-3105-11 D-1118-2022

Apr 13, 2022 Class II · Moderate risk

Cefazolin for injection USP

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0264-3103-11 D-1117-2022

Apr 13, 2022 Class II · Moderate risk

Diprivan (Propofol)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-269-29 D-1116-2022

Apr 13, 2022 Class II · Moderate risk

Diprivan (Propofol)

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-269-10 D-1115-2022

Apr 13, 2022 Class II · Moderate risk

Ofloxacin Otic Solution 0.3%

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 69238-1615-3 D-1114-2022

Apr 13, 2022 Class II · Moderate risk

Tetracaine Hydrochloride Ophthalmic Solution

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0065-0741-14 D-1113-2022

Apr 13, 2022 Class II · Moderate risk

Geodon for injection

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0049-3920-83 D-1112-2022

Apr 13, 2022 Class II · Moderate risk

Sumatriptan Succinate Tablets

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 62756-522-69 D-1111-2022

Apr 13, 2022 Class II · Moderate risk

Metoprolol tablets 50 mg

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 57664-0477-52 D-1110-2022

Apr 13, 2022 Class II · Moderate risk

Pilocarpine HCL Ophthalmic Solution

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office D-1109-2022

Apr 13, 2022 Class II · Moderate risk

Tropicamide Ophthalmic Solution

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office D-1108-2022

Apr 13, 2022 Class II · Moderate risk

Polymyxin B Sulfate and Trimethoprim Ophthalmic Solution

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office D-1107-2022

Apr 13, 2022 Class II · Moderate risk

Triamcinolone Acetonide cream

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0168-0004-15 D-1106-2022

Apr 13, 2022 Class II · Moderate risk

Prednisolone Acetate Ophthalmic Suspension

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 61314-637-05 D-1105-2022

Apr 13, 2022 Class II · Moderate risk

Pantoprazole Sodium for Injection

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0781-3232-95 D-1104-2022

Apr 13, 2022 Class II · Moderate risk

Ondansetron HCL

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 65862-188-30 D-1103-2022

Apr 13, 2022 Class II · Moderate risk

Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Ointment

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 61314-631-36 D-1102-2022

Apr 13, 2022 Class II · Moderate risk

Diphenhydramine HCl oral solution

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 0121-0978-10 D-1101-2022

Apr 13, 2022 Class II · Moderate risk

Verapamil HCL

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 04094-011-01 D-1100-2022

Apr 13, 2022 Class II · Moderate risk

Thrombin JMI

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 60793-215-05 D-1099-2022

Recalls by year

2026563
2025778
2024557
20231,122
20221,390
20211,152
2020930
20191,788
20181,681
20171,141
20161,199
20151,733
20141,309
20132,085
2012534
201134
20104
20072
20061